NCT04002752View on ClinicalTrials.gov

A Study of JNJ-73763989 in Healthy Japanese Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 4, 2019

Primary Completion Date

August 23, 2019

Study Completion Date

August 23, 2019

Conditions
Healthy
Interventions
DRUG

JNJ-73763989

Participants will receive JNJ-73763989 as single subcutaneous injection.

DRUG

Placebo

Participants will receive placebo matching to JNJ-73763989 as single subcutaneous injection.

Trial Locations (1)

HA1 3UJ

PAREXEL International, London

All Listed Sponsors
lead

Janssen Sciences Ireland UC

INDUSTRY

NCT04002752 - A Study of JNJ-73763989 in Healthy Japanese Adult Participants | Biotech Hunter | Biotech Hunter